World Janus Kinase (JAK) Inhibitors Competitive Landscape, Pipeline and Market Analysis 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Janus Kinase (JAK) Inhibitors - Competitive Landscape, Pipeline and Market Analysis - 2017" report to their offering.

This report provides information on the therapeutic development based on the Janus Kinase (JAK) Inhibitors dealing with all the pipeline drugs, comparative analysis of Janus Kinase (JAK) Inhibitors at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the company's information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

  1. Executive Summary
  2. Executive Summary Snapshot
  3. Overview
  4. Janus kinase Inhibitors (JAK Inhibitors)
  5. Mechanism of Action
  6. JAK Inhibitors Market Analysis
  7. Collaborations and Deals
  8. Acquisition Deals
  9. Designations Analysis
  10. Market Drivers
  11. Market Barriers
  12. Pipeline Therapeutics
  13. Companies Involved
  14. Therapeutics under Development by Companies
  15. Marketed and Pre-registration Stage Products
  16. Marketed Drugs
  17. Comparative Analysis
  18. Preclinical Products
  19. Comparative Analysis
  20. Therapeutic Assessment
  21. Dormant Products
  22. Comparative Analysis
  23. Companies involved in Therapeutics Development
  24. SWOT Analysis for JAK inhibitors
  25. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/f5tj4k/janus_kinase

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Oncology Drugs , Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Oncology Drugs , Enzymes